Company News

Share this article:

Aventis Pharmaceutical, a subsidiary of Sanofi-Aventis, will pay $95.5 million to settle Department of Justice allegations that it violated the False Claims Act by misreporting drug prices to reduce its Medicaid Drug Rebate obligations. The allegations refer to pricing on Azmacort, Nasacort and Nasacort AQ, between 1995 and 2000.

 

WeissComm Group announced the acquisition of Common Sense Media Group, a social media consulting company founded by Bob Pearson, who will become WeissComm's chief technology and media officer. WeissComm also signed a strategic alliance with Rule 13, a firm focused on social media education, research and training.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Panel votes against painkiller

Panel chair Randall Flick said QRxPharma "had not provided sufficient evidence to support a claim that Moxduo is safer than morphine or oxycodone."

Amgen sales rose by 5% in Q1

But demand for Enbrel and Aranesp slipped.

FDA reviews new painkiller

The candidate would be the first to put oxycodone and morphine in one capsule.